ARIAD PHARMACEUTICALS INC's ticker is and the CUSIP is 04033A900. A total of 3 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $5,476,000 | -54.5% | 440,200 | -49.9% | 0.05% | -59.5% |
| Q3 2016 | $12,039,000 | +120.5% | 879,400 | +19.0% | 0.13% | +101.5% |
| Q2 2016 | $5,460,000 | +146.8% | 738,800 | +113.5% | 0.06% | +109.7% |
| Q1 2016 | $2,212,000 | -42.1% | 346,100 | -43.4% | 0.03% | -31.1% |
| Q4 2015 | $3,822,000 | +39.5% | 611,500 | +30.4% | 0.04% | +18.4% |
| Q3 2015 | $2,740,000 | -55.0% | 469,100 | -36.3% | 0.04% | -55.3% |
| Q2 2015 | $6,088,000 | +199.8% | 736,100 | +198.6% | 0.08% | +165.6% |
| Q1 2015 | $2,031,000 | -79.8% | 246,500 | -83.1% | 0.03% | -78.9% |
| Q4 2014 | $10,041,000 | +57.5% | 1,461,600 | +23.8% | 0.15% | +55.1% |
| Q3 2014 | $6,377,000 | -26.5% | 1,180,900 | -13.3% | 0.10% | -26.9% |
| Q2 2014 | $8,673,000 | -43.2% | 1,361,500 | -28.2% | 0.13% | -47.9% |
| Q1 2014 | $15,281,000 | +54.0% | 1,895,900 | +30.3% | 0.26% | +71.3% |
| Q4 2013 | $9,920,000 | +315.9% | 1,454,600 | +1022.4% | 0.15% | +226.1% |
| Q3 2013 | $2,385,000 | +0.1% | 129,600 | -4.8% | 0.05% | -22.0% |
| Q2 2013 | $2,382,000 | – | 136,200 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 4,880 | $3,328,000 | 0.21% |
| GROUP ONE TRADING, L.P. | 1,454,600 | $9,920,000 | 0.15% |
| Citadel Advisors | 141,000 | $962,000 | 0.00% |